At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

Just as a rising tide is said to lift all boats, so too is a new FDA clearance expanding the reach of all of Boston Scientific’s WaveWriter spinal cord stimulation systems. The devices—which include ...

Boston Scientific is hopping on the bandwagon as the latest developer of a spinal cord stimulation system to receive FDA approval for diabetic neuropathy pain relief. The newly handed-down regulatory ...

Marlborough medical technology firm Boston Scientific has received approval from the U.S. Food and Drug Administration for its WaveWriter Alpha spinal cord stimulator device to be used to treat low ...

Boston Scientific was hit with a product liability lawsuit on Oct. 17 in California Central District Court over its WaveWriter Alpha spinal cord stimulator system. The action, brought by Davis & Crump ...